Study for association with dermatological adverse event induced by molecular targeted drugs and profile of body weigh dispersio
Not Applicable
- Conditions
- metastatic renal cell cancer
- Registration Number
- JPRN-UMIN000018948
- Lead Sponsor
- Department of Pharmacy, Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. hypersensitivity of sorafenib, sunitinib, or axitinib
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference of loading ratio in each planter region before treatment of multiple-tyrosine kinase inhibitors and ideal loading ratio of them in Japanese
- Secondary Outcome Measures
Name Time Method 1. 2. 3.